Quarterly Results Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Jun'25
Mar'25
Dec'24
Sep'24
Jun'24
Mar'24
Dec'23
Net Sales
1,085.82
876.90
832.85
938.04
1,132.97
1,000.34
766.59
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
1,085.82
876.90
832.85
938.04
1,132.97
1,000.34
766.59
Raw Material Cost
677.05
600.59
442.78
552.50
679.59
634.41
462.71
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
11.15
13.51
15.83
17.18
22.49
20.16
16.62
Selling and Distribution Expenses
165.15
117.77
165.75
67.54
126.02
104.19
141.81
Other Expenses
5.37
4.77
9.01
1.69
6.39
4.17
12.78
Total Expenditure (Excl Depreciation)
907.05
779.56
714.46
654.17
891.96
800.42
748.97
Operating Profit (PBDIT) excl Other Income
178.79999999999998
97.30000000000001
118.4
283.9
241
199.89999999999998
17.6
Other Income
-6.92
4.19
86.43
-33.67
45.73
24.95
0.24
Operating Profit (PBDIT)
280.04
160.24
362.33
299.99
324.47
262.59
-1,180.83
Interest
11.15
13.51
15.83
17.18
22.49
20.16
16.62
Exceptional Items
7.26
2.03
-15.21
14.27
-5.08
-4.21
-4.45
Gross Profit (PBDT)
408.77
276.31
390.07
385.53
453.39
365.93
303.88
Depreciation
58.72
58.72
49.80
49.80
37.72
37.72
44.84
Profit Before Tax
217.42
90.05
281.49
247.28
259.17
200.49
-1,246.73
Tax
15.87
8.03
64.76
46.52
31.35
23.31
-223.03
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
201.55
84.71
220.36
200.77
227.83
177.19
-1,028.75
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
201.55
84.71
220.36
200.77
227.83
177.19
-1,028.75
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
-0.00
-0.00
-0.04
-0.01
0.00
-0.00
-0.02
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
201.55
84.71
220.32
200.76
227.83
177.19
-1,028.78
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
6,605.63
6,576.88
6,491.67
6,270.41
6,070.04
5,982.03
5,801.97
Earnings per share (EPS)
0.13
0.05
0.12
0.12
0.14
0.11
-0.64
Diluted Earnings per share
0.13
0.05
0.12
0.12
0.14
0.11
-0.64
Operating Profit Margin (Excl OI)
21.02%
11.1%
27.15%
30.26%
21.27%
19.99%
-159.92%
Gross Profit Margin
25.43%
16.96%
39.78%
31.67%
26.21%
23.81%
-156.78%
PAT Margin
18.56%
9.66%
26.46%
21.4%
20.11%
17.71%
-134.2%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - QoQ
Net Sales
QoQ Growth in quarter ended Jun 2025 is 23.82% vs 5.30% in Mar 2025
Consolidate Net Profit
QoQ Growth in quarter ended Jun 2025 is 138.02% vs -61.55% in Mar 2025
Operating Profit (PBDIT) excl Other Income
QoQ Growth in quarter ended Jun 2025 is 83.86% vs -43.42% in Mar 2025
Interest
QoQ Growth in quarter ended Jun 2025 is -17.04% vs -14.56% in Mar 2025
Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Jun 2025 has improved from Mar 2025
Compare Quarterly Results Of Nanjing King-friend Biochemical Pharmaceutical Co., Ltd. With
Figures in Million
Consolidate Quarterly Results
Change(CNY)
Change(%)
Net Sales
1,085.82
0
1,085.82
Other Operating Income
0.00
0.00
0.00
Total Operating income
1,085.82
0
1,085.82
Raw Material Cost
677.05
0
677.05
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
11.15
0
11.15
Selling and Distribution Expenses
165.15
0
165.15
Other Expenses
5.37
0.00
5.37
Total Expenditure (Excl Depreciation)
907.05
0
907.05
Operating Profit (PBDIT) excl Other Income
178.77
0.00
178.77
Other Income
-6.92
0
-6.92
Operating Profit (PBDIT)
280.04
0
280.04
Interest
11.15
0
11.15
Exceptional Items
7.26
0
7.26
Gross Profit (PBDT)
408.77
0
408.77
Depreciation
58.72
0
58.72
Profit Before Tax
217.42
0
217.42
Tax
15.87
0
15.87
Provisions and contingencies
0
0
0.00
Profit After Tax
201.55
0
201.55
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
201.55
0
201.55
Share in Profit of Associates
0
0
0.00
Minority Interest
-0.00
0
-0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
201.55
0
201.55
Equity Capital
0
0
0.00
Face Value
1.00
0
0.00
Reserves
6,605.63
0
6,605.63
Earnings per share (EPS)
0.13
0
0.13
Diluted Earnings per share
0.13
0
0.13
Operating Profit Margin (Excl OI)
21.02%
0%
0.00
21.02%
Gross Profit Margin
25.43%
0%
0.00
25.43%
PAT Margin
18.56%
0%
0.00
18.56%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 108.58 Million
in Jun 2025Figures in Million
QoQ Growth in quarter ended Jun 2025 is 23.82% vs 5.30% in Mar 2025
YoY Growth in quarter ended Jun 2025 is -4.17% vs 14.77% in Jun 2024
Quarterly - Consolidate Net Profit
Consolidate Net Profit 20.16 Million
in Jun 2025Figures in Million
QoQ Growth in quarter ended Jun 2025 is 138.02% vs -61.55% in Mar 2025
YoY Growth in quarter ended Jun 2025 is -11.50% vs -22.04% in Jun 2024
Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 28.70 Million
in Jun 2025Figures in Million
QoQ Growth in quarter ended Jun 2025 is 83.86% vs -43.42% in Mar 2025
YoY Growth in quarter ended Jun 2025 is 2.98% vs 10.51% in Jun 2024
Quarterly - Interest
Interest 1.12 Million
in Jun 2025Figures in Million
QoQ Growth in quarter ended Jun 2025 is -17.04% vs -14.56% in Mar 2025
YoY Growth in quarter ended Jun 2025 is -50.22% vs 8.17% in Jun 2024
Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 21.02%
in Jun 2025Figures in %
QoQ Growth in quarter ended Jun 2025 has improved from Mar 2025
YoY Growth in quarter ended Jun 2025 has fallen from Jun 2024
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
